Onc.AI is a precision oncology AI platform that analyzes routine clinical CT scans to predict treatment response and patient outcomes. Its core deep-learning products, Onclara Evaluate and Onclara IO, process diagnostic imaging to extract radiomic biomarkers, tumor burden metrics, and body composition data without requiring manual annotations. The platform enables oncologists and pharmaceutical companies to stratify risk, balance clinical trial arms, and inform critical treatment decisions.

AI-powered technology bringing clarity to cancer treatment

Key features

Automated Imaging Biomarker Extraction: Extracts radiomic signatures, tumor burden, vascular morphology, and body composition metrics directly from baseline CT scans without manual annotation.
Onclara Evaluate: FDA Breakthrough-designated AI tool that calculates calibrated 12-month overall survival probabilities and stratifies risk in advanced solid tumors like mNSCLC.
Onclara IO: Predicts treatment response and survival outcomes specifically for patients receiving immunotherapy.
Clinical Trial Stratification & Matching: Supports early-phase pharma decision-making with propensity score matching, arm balancing, and response comparison across dose levels

Strengths

FDA Breakthrough Device Designation for advanced clinical trial decision-making
Completely automated pipeline requiring zero manual image annotation by radiologists or oncologists
Extracts deep-learning biomarkers that outperform standard RECIST metrics for overall survival prediction

Best for

Oncologists seeking objective, AI-driven survival predictions and imaging biomarker insights for cancer treatment planning
Biopharma companies and CROs conducting Phase IB/II solid tumor clinical trials and requiring patient stratification

Integrations

Microsoft Azure AI Foundry (native, deep, system)
Oncology EMR Systems (api, deep, system)

onc.ai

Onc.AI

Key features

Strengths

Best for

Integrations

Categories

Features

Add Review

Leave a Reply Cancel reply

Added By Maylana